Life Sciences
Canada NewsWire Nurosene's Chief Scientific Officer, Dr. Joseph Geraci PhD, publishes a paper in collaboration with highly-renowned researchers on using AI to address placebo...
Hi, what are you looking for?
Canada NewsWire Nurosene's Chief Scientific Officer, Dr. Joseph Geraci PhD, publishes a paper in collaboration with highly-renowned researchers on using AI to address placebo...
Canada NewsWire / NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER, May 19, 2022 /CNW/ - Mydecine Innovations Group...
Canada NewsWire Nurosene's proprietary AI technology was utilized to help understand a psychiatric drug response profile for a mental health patient clinical trial. TORONTO,...
Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER, May 18, 2022 /CNW/ - Mydecine Innovations Group Inc....
Mydecine Announces First Quarter 2022 Financial Results and HighlightsDENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE:...
Medivolve Announces Q1 2022 Financial Results Cash on hand was $8,327,812 as at March 31, 2022, up 7,309% compared to $112,397 as at December...
LEXSTONS Directors Approve Five to One Share Consolidation (TheNewswire) Vancouver, British Columbia – TheNewswire - May 13, 2022. Lexston Life Sciences Corp. (the “Company”...
CSE Bulletin: Name & Symbol Change and Consolidation - Feel Foods Ltd. (FEEL)Toronto, Ontario--(Newsfile Corp. - Le 13 mai/May 2022) - Feel Foods Ltd....
American Billionaire Entrepreneurs Bet Millions on Psychedelics FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob...
Canada NewsWire Nurosene will utilize Cove's powerful brain analysis platform to deliver actionable precision recommendations in the Nuro App. TORONTO, May 6, 2022 /CNW/...